PlexusDx prescribers monitor progress through follow-up consultations and adjust your treatment plan as needed
Long-term use beyond 23 months is not recommended
PlexusDx's precision-wellness model combines compounded medications from licensed 503A pharmacies with optional genetic testing to support a more informed dialogue between patient and provider
Julien O, Wells JA
Use the sliders to calculate your BMI and determine eligibility
- when there is risk of torsades de pointes, for example in patients with prolonged QT, concomitant administration of other medications that produce torsades de pointes (amiodarone, quinidine, bepridil, IV erythromycin, halofrantine, pentamidine, sparfloxacin, sultopride, vincamine, betrilio, disopyramide, sotalol, etc)